Stockscreener 앱 받기
39.67
0.08%
-0.03
전일 마감가:
$39.70
열려 있는:
$39.8
하루 거래량:
736.56K
Relative Volume:
0.29
시가총액:
$6.14B
수익:
$15.06M
순이익/손실:
$-197.82M
주가수익비율:
-27.23
EPS:
-1.4568
순현금흐름:
$-194.64M
1주 성능:
+0.53%
1개월 성능:
-0.05%
6개월 성능:
+76.15%
1년 성능:
+192.34%
1일 변동 폭
$39.62
$39.84
1주일 범위
$39.35
$39.84
52주 변동 폭
$10.95
$40.26
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
명칭
Centessa Pharmaceuticals Plc Adr
전화
44 7391 789784
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
39.67 | 6.14B | 15.06M | -197.82M | -194.64M | -1.4568 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2026-02-24 | 개시 | Wolfe Research | Outperform |
| 2025-12-10 | 재개 | Oppenheimer | Outperform |
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 개시 | Wells Fargo | Overweight |
| 2025-08-29 | 재개 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-05-08 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-07-18 | 개시 | Oppenheimer | Outperform |
| 2023-11-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-10-26 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 개시 | Evercore ISI | Outperform |
| 2023-06-12 | 개시 | Guggenheim | Buy |
| 2023-03-17 | 개시 | SVB Securities | Outperform |
| 2022-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-02-11 | 개시 | Goldman | Neutral |
모두보기
Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스
LLY to buy neuroscience biotech Centessa Pharmaceuticals in $7.8B deal - MSN
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 - GlobeNewswire Inc.
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 12-Month HighStill a Buy? - MarketBeat
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN
Centessa (NASDAQ: CNTA) schedules 2026 AGM and advisory pay vote - Stock Titan
38,432 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Acquired by B. Metzler seel. Sohn & Co. AG - MarketBeat
Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35 - marketscreener.com
Lilly to buy Centessa (NASDAQ: CNTA) for $38/ share plus $9 CVR - Stock Titan
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? - Finviz
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? - Sahm
Free cash flow per share of Centessa Pharmaceuticals PLC ADR – MUN:260 - TradingView
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy - Sahm
This Akamai Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Sahm
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – What’s Next? - Defense World
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA) - Sahm
Centessa Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:CNTA) - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal - Yahoo Finance
JPMorgan Chase & Co. Sells 186,539 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
SG Americas Securities LLC Buys 240,039 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits all-time high at 40.03 USD By Investing.com - Investing.com South Africa
Weight-Loss Drug Giant Eli Lilly Bets Big Again. Spending $7.8 Billion to Acquire Centessa, Is Now a Good Time to Buy Eli Lilly? - TradingKey
Lilly (NYSE: LLY) buying Centessa (NASDAQ: CNTA) for $38 plus CVR - Stock Titan
Options Traders Pick Up Pharma Stock After Eli Lilly Buyout - Finviz
Gold Gains Over 1%; FactSet Research Raises FY2026 OutlookApellis Pharmaceuticals (NASDAQ:APLS), Cente - Benzinga
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders - Barchart.com
Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):